• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Angi Inc. downgraded by Goldman with a new price target

    11/13/24 7:30:03 AM ET
    $ANGI
    Advertising
    Consumer Discretionary
    Get the next $ANGI alert in real time by email
    Goldman downgraded Angi Inc. from Buy to Neutral and set a new price target of $2.50 from $3.25 previously
    Get the next $ANGI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ANGI

    DatePrice TargetRatingAnalyst
    6/16/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    12/18/2024Overweight → Neutral
    Analyst
    11/13/2024$3.25 → $2.50Buy → Neutral
    Goldman
    11/13/2024$3.25 → $2.00Buy → Neutral
    Citigroup
    7/9/2024$3.25Mkt Outperform
    JMP Securities
    2/15/2023$2.00 → $2.75Sell → Neutral
    UBS
    12/13/2022$2.60Buy
    Citigroup
    12/2/2022$2.00Sell
    UBS
    More analyst ratings